Floatz logo

ETHYLICUM

Liver Fibroses

Odense University HospitalSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

27 Active assets in the Liver Fibroses cohort.

Asset / SponsorPhaseRating
Entecavir
Tanta University
Phase 4BB
Peg-Intron
Beth Israel Deaconess Medical Center
Phase 4BB
COLCHICINUM
Zagazig University
Phase 4BB
Peg-Ifn
Beijing Friendship Hospital
Phase 4BB
Hydronidone
Beijing Continent Pharmaceutical Co, Ltd.
Phase 3BB

View all 50 →

Same molecule, other indications

ETHYLICUM is also rated in:

malignant pancreatic neoplasmDormant
BB
Indicative ·
66 / 100
View asset →
Abdominal CancerDormant
BB
Indicative ·
66 / 100
View asset →
cancer-related conditionDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →